Pharmacy

The elimination of drugs and their metabolites from the body primarily through urine or feces. Documented in EHR clinical pharmacology records and PBM drug databases to inform dosing intervals, renal or hepatic adjustment flags, and drug utilization review edits applied during pharmacy claims processing.

The date after which a medication should not be used due to potential loss of potency or safety. Stored in pharmacy dispensing systems and PBM drug master files as a critical validation field, triggering rejection edits during claims adjudication when dispensed medication lot dates exceed the manufacturer-assigned expiration threshold.

The preparation of a customized medication by a licensed pharmacist in response to a specific patient prescription not available as a commercial product. Tracked in pharmacy dispensing and PBM systems using compound claim transaction codes, requiring special pricing logic, NDC placeholder values, and manual review workflows during adjudication.

A drug formulation designed to release medication slowly over an extended period to maintain therapeutic levels and reduce dosing frequency. Identified in pharmacy and PBM systems via specific NDC codes and dose form descriptors, impacting DAW codes, days-supply calculations, and formulary tier assignments during claims adjudication.

The German federal regulatory agency responsible for approving and monitoring drugs and medical devices in Germany. Equivalent to the US FDA for the German market. BfArM drug approval data is referenced in international pharmaceutical research and global drug safety monitoring systems.

An inactive ingredient or placeholder component in pharmaceutical formulations, tracked in drug master data systems and PBM formulary databases alongside NDC records. In HL7 messaging contexts, filler also refers to the entity fulfilling an order, such as a laboratory or pharmacy, relevant to EHR order management and claims reconciliation workflows.

A data processing operation applied within healthcare ETL pipelines, reporting layers, or query engines to include or exclude records based on defined criteria such as date ranges, claim status codes, or member eligibility flags. Used extensively across EHR, payer, and PBM data platforms to scope datasets for analytics, compliance reporting, and cohort identification.

An inactive pharmaceutical ingredient added to improve palatability of medications, cataloged in drug master files and PBM formulary systems using NDC and ingredient classification codes. Relevant in specialty and compounding pharmacy data systems where flavoring agent details are captured in prescription records and may affect drug pricing, formulary classification, and dispensing validation logic.

The federal agency responsible for regulating prescription and over-the-counter drugs, medical devices, biologics, and food safety in the United States. FDA approval is required before drugs can be marketed and sold. FDA drug codes and NDC numbers are foundational identifiers in pharmacy data systems.

A curated list of prescription drugs approved and covered by a health plan, PBM, or healthcare organization, typically organized into cost-sharing tiers. Used in pharmacy and PBM systems to determine drug eligibility, copay levels, and prior authorization requirements during adjudication and claims processing.

The specific physical composition and delivery form of a drug product, such as tablet, capsule, liquid, or extended-release, as recorded in pharmacy, PBM, and EHR systems. Data engineers use formulation attributes to distinguish between drug variants during formulary matching, medication reconciliation, and NDC-level claims analysis.

Standardized medication frequency abbreviation QID, derived from Latin 'quater in die,' specifying four administrations per day. Widely used in EHR order sets, pharmacy systems, and PBM claims processing to define dosing intervals, validate prescription instructions, and calculate day-supply quantities.

Abbreviated as QID (from Latin 'quater in die'), this dosing frequency instructs medication administration four times per day, typically every six hours. Used in EHR medication order entry, pharmacy dispensing systems, and medication administration records to define prescription schedules and calculate daily dose totals.

A pharmacy operation licensed to a franchisor that operates under a standardized brand and business model. Franchise pharmacies combine independent ownership with chain-like operational standards. Identified in pharmacy claims data by NCPDP provider ID and pharmacy type code.

Furosemide (brand: Lasix) is a loop diuretic tracked in pharmacy, PBM, and EHR medication administration records. In claims data, it appears under NDC and GPI codes and is monitored in chronic kidney disease, heart failure, and hypertension quality measure reporting and drug utilization review programs.

A semisolid dosage form classification in pharmacy and drug master file systems where solid particles are dispersed in liquid, used for topical, transdermal, or oral administration. Coded in RxNorm and NDC drug databases to support formulary management, route-of-administration logic, and dispensing workflows in EHR and PBM platforms.

A medication equivalent to a brand-name drug in active ingredient, dosage, strength, and route of administration, identified in PBM and pharmacy systems via GPI or NDC codes. Used in formulary tiering, claims adjudication, and drug substitution logic across EHR, pharmacy dispensing, and member benefits management platforms to drive cost management.

GMO in healthcare data contexts appears within clinical research, pharmacogenomics, and biologic drug tracking systems. Data engineers encounter GMO-related metadata in investigational drug databases, FDA submission records, and EHR genomic annotation fields tied to biologic therapy eligibility and clinical trial enrollment data pipelines.

A pharmacy specialty focused on medication management for elderly patients with complex medication regimens and age-related physiological changes. Geriatric pharmacists optimize drug therapy to reduce polypharmacy risks, prevent adverse drug events, and improve outcomes in Medicare Advantage and long-term care populations.

A specialized containment equipment designation in pharmacy compounding and sterile preparation systems indicating drug preparation occurs in an enclosed, controlled atmosphere environment. Referenced in compounding pharmacy records, USP 797/800 compliance documentation, and EHR pharmacy order systems to ensure hazardous drug handling and safety protocol adherence.